Muirhead Corinne A, Sanford Jillian N, McCullar Benjamin G, Nolt Dawn, MacDonald Kelvin D
Department of Pharmacy, Oregon Health and Science University, Doernbecher Children's Hospital, Portland, OR, USA.
Department of Pediatrics, Oregon Health and Science University, Doernbecher Children's Hospital, Portland, OR, USA.
Clin Med Insights Pediatr. 2016 Jul 12;10:57-65. doi: 10.4137/CMPed.S38336. eCollection 2016.
Cystic fibrosis (CF) is a chronic disorder characterized by acute pulmonary exacerbations that comprise increased cough, chest congestion, increased mucus production, shortness of breath, weight loss, and fatigue. Typically, severe episodes are treated in the inpatient setting and include intravenous antimicrobials, airway clearance therapy, and nutritional support. Children with less-severe findings can often be managed as outpatients with oral antimicrobials and increased airway clearance therapy at home without visiting the specialty CF center to begin treatment. Selection of specific antimicrobial agents is dependent on pathogens found in surveillance culture, activity of an agent in patients with CF, and the unique physiology of these patients. In this pediatric review, we present our practice for defining acute pulmonary exacerbation, deciding treatment location, initiating treatment either in-person or remotely, determining the frequency of airway clearance, selecting antimicrobial therapy, recommending timing for follow-up visit, and recognizing and managing treatment failures.
囊性纤维化(CF)是一种慢性疾病,其特征为急性肺部加重,表现为咳嗽加剧、胸部充血、黏液分泌增加、呼吸急促、体重减轻和疲劳。通常,严重发作需在住院环境中治疗,包括静脉使用抗菌药物、气道清除治疗和营养支持。症状较轻的儿童通常可作为门诊患者,在家中使用口服抗菌药物并增加气道清除治疗,无需前往专科CF中心开始治疗。特定抗菌药物的选择取决于监测培养中发现的病原体、该药物在CF患者中的活性以及这些患者的独特生理状况。在这篇儿科综述中,我们介绍了我们在定义急性肺部加重、决定治疗地点、亲自或远程启动治疗、确定气道清除频率、选择抗菌治疗、推荐随访时间以及识别和处理治疗失败方面的做法。